Christiane Reitz1,2,3,4, Vanessa A Guzman1, Atul Narkhede1, Charles DeCarli5,6, Adam M Brickman1,2,3, José A Luchsinger4,7. 1. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York City, New York. 2. Department of Neurology, College of Physicians and Surgeons, Columbia University, New York City, New York. 3. Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York City, New York. 4. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York. 5. Department of Neurology, Center for Neuroscience, University of California at Davis, Sacramento, California. 6. Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California at Davis, Sacramento, California. 7. Department of Medicine, College of Physicians and Surgeons, Columbia University, New York City, New York.
Abstract
OBJECTIVES: Abnormally high glucose levels (dysglycemia) increase with age. Epidemiological studies suggest that dysglycemia is a risk factor for cognitive impairment but the underlying pathophysiological mechanisms remain unclear. The objective of this study was to examine the relation of dysglycemia clinical categories (normal glucose tolerance (NGT), pre-diabetes, undiagnosed diabetes, known diabetes) with brain structure in older adults. We also assessed the relation between dysglycemia and cognitive performance. DESIGN: Cross-sectional and longitudinal cohort study. SETTING: Northern Manhattan (Washington Heights, Hamilton Heights, and Inwood). PARTICIPANTS: Medicare recipients 65 years and older. MEASUREMENTS: Dysglycemia categories were based on HBA1c or history of type 2 diabetes (diabetes). Brain structure (brain infarcts, white matter hyperintensities (WMH) volume, total gray matter volume, total white matter volume, total hippocampus volume) was assessed with brain magnetic resonance imaging; cognitive function (memory, language and visuospatial function, speed) was assessed with a validated neuropsychological battery. RESULTS: Dysglycemia, defined with HbA1c as a continuous variable or categorically as pre-diabetes and diabetes, was associated with a higher number of brain infarcts, WMH volume and decreased total white matter, gray matter and hippocampus volumes cross-sectionally, and a significant decline in gray matter volume longitudinally. Dysglycemia was also associated with lower performance in language, speed and visuospatial function although these associations were attenuated when adjusted for education, APOE-ε4, ethnic group and vascular risk factors. CONCLUSION: Our results suggest that dysglycemia affects brain structure and cognition even in elderly survivors, evidenced by higher cerebrovascular disease, lower white and gray matter volume, and worse language and visuospatial function and cognitive speed.
OBJECTIVES: Abnormally high glucose levels (dysglycemia) increase with age. Epidemiological studies suggest that dysglycemia is a risk factor for cognitive impairment but the underlying pathophysiological mechanisms remain unclear. The objective of this study was to examine the relation of dysglycemia clinical categories (normal glucose tolerance (NGT), pre-diabetes, undiagnosed diabetes, known diabetes) with brain structure in older adults. We also assessed the relation between dysglycemia and cognitive performance. DESIGN: Cross-sectional and longitudinal cohort study. SETTING: Northern Manhattan (Washington Heights, Hamilton Heights, and Inwood). PARTICIPANTS: Medicare recipients 65 years and older. MEASUREMENTS: Dysglycemia categories were based on HBA1c or history of type 2 diabetes (diabetes). Brain structure (brain infarcts, white matter hyperintensities (WMH) volume, total gray matter volume, total white matter volume, total hippocampus volume) was assessed with brain magnetic resonance imaging; cognitive function (memory, language and visuospatial function, speed) was assessed with a validated neuropsychological battery. RESULTS: Dysglycemia, defined with HbA1c as a continuous variable or categorically as pre-diabetes and diabetes, was associated with a higher number of brain infarcts, WMH volume and decreased total white matter, gray matter and hippocampus volumes cross-sectionally, and a significant decline in gray matter volume longitudinally. Dysglycemia was also associated with lower performance in language, speed and visuospatial function although these associations were attenuated when adjusted for education, APOE-ε4, ethnic group and vascular risk factors. CONCLUSION: Our results suggest that dysglycemia affects brain structure and cognition even in elderly survivors, evidenced by higher cerebrovascular disease, lower white and gray matter volume, and worse language and visuospatial function and cognitive speed.
Authors: Paul K Crane; Rod Walker; Rebecca A Hubbard; Ge Li; David M Nathan; Hui Zheng; Sebastien Haneuse; Suzanne Craft; Thomas J Montine; Steven E Kahn; Wayne McCormick; Susan M McCurry; James D Bowen; Eric B Larson Journal: N Engl J Med Date: 2013-08-08 Impact factor: 91.245
Authors: Fumiko Irie; Annette L Fitzpatrick; Oscar L Lopez; Lewis H Kuller; Rita Peila; Anne B Newman; Lenore J Launer Journal: Arch Neurol Date: 2008-01
Authors: Geert Jan Biessels; Mark W J Strachan; Frank L J Visseren; L Jaap Kappelle; Rachel A Whitmer Journal: Lancet Diabetes Endocrinol Date: 2013-10-18 Impact factor: 32.069
Authors: Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux Journal: Arch Neurol Date: 2012-12
Authors: Rosebud O Roberts; David S Knopman; Scott A Przybelski; Michelle M Mielke; Kejal Kantarci; Gregory M Preboske; Matthew L Senjem; Vernon S Pankratz; Yonas E Geda; Bradley F Boeve; Robert J Ivnik; Walter A Rocca; Ronald C Petersen; Clifford R Jack Journal: Neurology Date: 2014-03-19 Impact factor: 9.910
Authors: I Bourdel-Marchasson; G Catheline; S Regueme; M Danet-Lamasou; E Barse; F Ratsimbazafy; L Rodriguez-Manas; K Hood; A J Sinclair Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: Rainer J Klement; Petra S Koebrunner; Kelley Krage; Michael M Weigel; Reinhart A Sweeney Journal: Med Oncol Date: 2020-11-28 Impact factor: 3.064
Authors: Gargi Mahapatra; S Carrie Smith; Timothy M Hughes; Benjamin Wagner; Joseph A Maldjian; Barry I Freedman; Anthony J A Molina Journal: Clin Sci (Lond) Date: 2018-12-05 Impact factor: 6.124
Authors: Frauke Beyer; Shahrzad Kharabian Masouleh; Jürgen Kratzsch; Matthias L Schroeter; Susanne Röhr; Steffi G Riedel-Heller; Arno Villringer; A Veronica Witte Journal: Front Aging Neurosci Date: 2019-08-02 Impact factor: 5.750
Authors: Melissa Lamar; Elizabeth A Boots; Konstantinos Arfanakis; Lisa L Barnes; Julie A Schneider Journal: Neuropsychol Rev Date: 2020-10-03 Impact factor: 7.444